Bennett RG - Search Results

1

Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease.

Zhang C, Hang Y, Tang W, Sil D, Jensen-Smith HC, Bennett RG, McVicker BL, Oupický D. Zhang C, et al. Among authors: bennett rg. Pharmaceutics. 2022 Mar 18;14(3):669. doi: 10.3390/pharmaceutics14030669. Pharmaceutics. 2022. PMID: 35336043 Free PMC article.

2

Novel Anti-fibrotic Therapies.

McVicker BL, Bennett RG. McVicker BL, et al. Among authors: bennett rg. Front Pharmacol. 2017 May 31;8:318. doi: 10.3389/fphar.2017.00318. eCollection 2017. Front Pharmacol. 2017. PMID: 28620300 Free PMC article. Review.

3

A Selective PPARγ Modulator Reduces Hepatic Fibrosis.

McVicker BL, Hamel FG, Simpson RL, Bennett RG. McVicker BL, et al. Among authors: bennett rg. Biology (Basel). 2020 Jul 2;9(7):151. doi: 10.3390/biology9070151. Biology (Basel). 2020. PMID: 32630819 Free PMC article.

4

Polymeric Chloroquine as an Effective Antimigration Agent in the Treatment of Pancreatic Cancer.

Khan R, Panja S, Ding L, Tang S, Tang W, Kapoor E, Bennett RG, Oupický D. Khan R, et al. Among authors: bennett rg. Mol Pharm. 2022 Dec 5;19(12):4631-4643. doi: 10.1021/acs.molpharmaceut.2c00596. Epub 2022 Nov 8. Mol Pharm. 2022. PMID: 36346968

5

Alcohol-induced tubulin post-translational modifications directly alter hepatic protein trafficking.

Adhikari R, Mitra R, Bennett RG, McVicker BL, Tuma PL. Adhikari R, et al. Among authors: bennett rg. Hepatol Commun. 2023 Mar 24;7(4):e0103. doi: 10.1097/HC9.0000000000000103. eCollection 2023 Apr 1. Hepatol Commun. 2023. PMID: 36972397 Free PMC article.

6

Reduction in Obesity-Related Hepatic Fibrosis by SR1664.

McVicker BL, Simpson RL, Hamel FG, Bennett RG. McVicker BL, et al. Among authors: bennett rg. Biology (Basel). 2023 Sep 26;12(10):1287. doi: 10.3390/biology12101287. Biology (Basel). 2023. PMID: 37886997 Free PMC article.

7

Targeting the Relaxin Pathway for Liver Disease Treatment.

Bennett RG. Bennett RG. Eur Med J Hepatol. 2018 May;6(1):80-87. Epub 2018 May 31. Eur Med J Hepatol. 2018. PMID: 31360529 Free PMC article.

8

Relaxin decreases the severity of established hepatic fibrosis in mice.

Bennett RG, Heimann DG, Singh S, Simpson RL, Tuma DJ. Bennett RG, et al. Liver Int. 2014 Mar;34(3):416-26. doi: 10.1111/liv.12247. Epub 2013 Jul 21. Liver Int. 2014. PMID: 23870027 Free PMC article.

9

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.

Bennett RG, Simpson RL, Hamel FG. Bennett RG, et al. World J Gastroenterol. 2017 Jun 14;23(22):3999-4006. doi: 10.3748/wjg.v23.i22.3999. World J Gastroenterol. 2017. PMID: 28652653 Free PMC article.

10

Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis.

Bennett RG, Heimann DG, Tuma DJ. Bennett RG, et al. Ann N Y Acad Sci. 2009 Apr;1160:348-9. doi: 10.1111/j.1749-6632.2008.03783.x. Ann N Y Acad Sci. 2009. PMID: 19416217 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page